Prescient Therapeutics (PTX.AX) Daily Performance
- Closing price: AUD 0.06
- Price change (24 h): –1.72 %
- Current market capitalization: AUD 66.3 million
- Shares outstanding: 1.2 billion
- Volume (last 24 h): AUD 25 000
The stock traded down 16.18 % since the end of the previous month. The 200‑day simple moving average is AUD 0.07. The 52‑week high was AUD 0.12 on 12 17 2025; the 52‑week low was AUD 0.04 on 11 07 2025.
Comparative Performance of Related ASX All Markets Stocks (Last 24 h)
| Symbol | Current price (AUD) | Change (24 h) | Market cap (AUD m) |
|---|---|---|---|
| EVO.AX (Embark Early Education) | 0.38 | –2.6 % | 76.4 |
| DAI.AX (Decidr Ai Industries) | 0.22 | –4.35 % | 77.5 |
| LNQ.AX (Linq Minerals) | 0.54 | +40.54 % | 75.9 |
| LRK.AX (Lark Distilling) | 0.70 | –1.38 % | 77.9 |
| LM8.AX (Lunnon Metals) | 0.33 | –4.48 % | 76.2 |
| LM8.AX | 0.33 | –4.48 % | 76.2 |
| P/E Ratio | 6.57 |
Company Overview
Prescient Therapeutics Ltd. is an Australian health‑care biotechnology company headquartered in Southbank. The company focuses on the research, development, and commercialization of novel cancer therapies for multiple cancer types, including myeloma, breast, and pancreatic cancers. Its operations are listed on the ASX All Markets exchange. For detailed information, visit the company website at www.prescienttherapeutics.com .
